CTI BioPharma Corp. (NASDAQ:CTIC) Receives Average Rating of "Moderate Buy" from Brokerages : vimarsana.com

Shares of CTI BioPharma Corp. (NASDAQ:CTIC – Get Rating) have been assigned a consensus rating of “Moderate Buy” from the eight ratings firms that are covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a hold rating and seven have issued a buy rating on the company. The average 1 […]

Related Keywords

Jamesk Fong , Adamr Craig , , E Fund Management Co , Biopharma Company Profile , Fund Management Co , Bartlett Co , Needham Company , Ghost Tree Capital , Biopharma Corp , Nasdaq , Perceptive Advisors , Securities Exchange Commission , Get Rating , Pharma Stock Down , Exchange Commission , Capital Management , Tree Capital , Fund Management , Pharma Company , Pharma Daily , Cti Biopharma , Nasdaq Ctic , Rctic , Medical , Ratings , Consensus ,